Literature DB >> 11225692

Applying social skills training in the context of vocational rehabilitation for people with schizophrenia.

H W Tsang1.   

Abstract

This paper describes a model for the conceptualization of social skills necessary for the vocational success of people with schizophrenia. Based on this model, a two-part measure was developed and validated to assess social skills necessary for job search and tenure. The measure consists of a 10-item self-administered checklist and a role-play exercise. The self-administered checklist measures clients' perceived competence in handling work-related social situations. The role-play exercise assesses the social skills necessary for job acquisition and maintenance in two simulated situations (participating in a simulated job interview and requesting urgent leave from work). Furthermore, a social skills training module has been designed, which enhances vocational outcome and fills a gap in the existing, commonly used modules. A pilot study shows that the training module together with appropriate professional support afterward is effective in enhancing the social competence and vocational outcomes of persons with schizophrenia. Implications for cross-cultural applications are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11225692     DOI: 10.1097/00005053-200102000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  [Sociotherapy in German social law. Indication, contents, and aspects of public health].

Authors:  R-M Frieboes
Journal:  Nervenarzt       Date:  2003-06-13       Impact factor: 1.214

2.  Cognitive training plus a comprehensive psychosocial programme (OPUS) versus the comprehensive psychosocial programme alone for patients with first-episode schizophrenia (the NEUROCOM trial): a study protocol for a centrally randomised, observer-blinded multi-centre clinical trial.

Authors:  Lone Vesterager; Torben Ø Christensen; Birthe B Olsen; Gertrud Krarup; Hysse B Forchhammer; Marianne Melau; Christian Gluud; Merete Nordentoft
Journal:  Trials       Date:  2011-02-09       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.